AZ Delta Roeselare Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2011
NCT01428973
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

AZ Delta | AZ Delta Roeselare | AZ Delta Roeselare-Menen | Orthopedie Roeselare AZ Delta

Active Ingredients

Drugs in Phase 4 Trials (4)

ketamine (ketalar) (1 trial)

mepolizumab (Nucala) (1 trial)

omalizumab (xolair) (1 trial)

onabotulinumtoxinA (Botox) (1 trial)

Drugs in Phase 3 Trials (1)

semaglutide (Ozempic) (1 trial)

Drugs in Phase 2 Trials (2)

mycophenolate (CellCept) (1 trial)

sirolimus (rapamune) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 4)

Graft vs Host Disease (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 7